The American Journal of Medicine
Volume 120, Issue 1 , Pages 98.e1-98.e8 , January 2007

Use of Disease-Modifying Therapies in Patients Hospitalized with Heart Failure: A Population-Based Perspective

Received 19 May 2006 ,Accepted 19 May 2006.

References 

  1. American Heart Association. 2005 Heart and Stroke Statistical Update.. Dallas, TX: American Heart Association; 2004;
  2. U.S. Department of Health and Human ServicesNational Institutes of Health. Morbidity and Mortality Chartbook on Cardiovascular Lung And Blood Diseases, 2002.. Bethesda, MD: National Heart, Lung and Blood Institute; 2002;
  3. Konstam MA, Dracup K, Baker DW, et al. Heart Failure: Evaluation and Care of Patients with Left Ventricular Systolic Dysfunction. (Clinical Practice Guideline No. 11, AHCPR Publication No. 94-0612). Rockville, MD: U.S. Department of Health and Human Services; 1995;
  4. Haldeman GA, Croft JB, Giles WH, Rashidee A. Hospitalization of patients with heart failure: National Hospital Discharge Survey, 1985 to 1995. Am Heart J. 1999;137:352–360
  5. Hunt SA, Baker DW, Chin MH, et al. American College of Cardiology/American Heart Association ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary (A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure)). J Am Coll Cardiol. 2001;38:2101–2113
  6. Brater DC. Drug therapy: diuretic therapy. N Engl J Med. 1998;339:387–395
  7. Millane T, Jackson G, Gibbs CR, Lip GY. ABC of heart failure (Acute and chronic management strategies). Br Med J. 2000;320:559–562
  8. Gheorghiade M, Cody RJ, Francis G, McKenna WJ, Young JB, Bonow RO. Current medical therapy for advanced heart failure. Heart Lung. 2000;29:19–32
  9. Linehan DJ, Uretsky BF. Nonpharmacologic treatment of heart failure in the elderly. Clin Geriatr Med. 2000;16:477–487
  10. Nohria A, Chen YT, Morton DJ, Walsh R, Vlasses PH, Krumholz HM. Quality of care for patients hospitalized with heart failure at academic medical centers. Am Heart J. 1999;137:1028–1034
  11. Krumholz HM, Wang Y, Parent EM, Mockalis J, Petrillo M, Radford MJ. Quality of care for elderly patients hospitalized with heart failure. Arch Intern Med. 1997;157:2242–2247
  12. Philbin EF, Andreaou C, Rocco TA, Lynch LJ, Baker SL. Patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure in two community hospitals. Am J Cardiol. 1996;77:832–838
  13. Goldberg RJ, Spencer FA, Farmer C, Meyer TE, Pezzella S. Incidence and hospital death rates associated with heart failure: a community-wide perspective. Am J Med. 2005;118:728–734
  14. Ho KKL, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: The Framingham Study. J Am Coll Cardiol. 1993;22(Suppl A):6A–13A
  15. Vasan RS, Larson MG, Benjamin EJ, Evans JC, Reiss CK, Levy D. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol. 1999;33:1948–1955
  16. Baker DW, Konstam MA, Bottorff M, Pitt B. Management of heart failure (I. Pharmacologic treatment). JAMA. 1994;272:1361–1366
  17. Hadorn DC, Baker DW, Kamberg CJ, Brooks RH. Phase II of the AHCPR-sponsored heart failure guideline: translating practice recommendation into review criteria. Jt Comm Qual Improv. 1996;22:265–276
  18. Bart BA, Gattis WA, Diem SJ, O’Connor CM. Reasons for underuse of angiotensin converting enzyme inhibitors in patients with heart failure and left ventricular dysfunction. Am J Cardiol. 1997;79:1118–1120
  19. McDermott MM, Lee P, Mehta S, Gheorghiade M. Patterns of angiotensin-converting enzyme inhibitor prescriptions, educational interventions, and outcomes among hospitalized patients with heart failure. Clin Cardiol. 1998;21:261–268
  20. McDermott MM, Feinglass J, Lee P, et al. Heart failure between 1986 and 1994: temporal trends in drug-prescribing practices, hospital readmissions, and survival at an academic medical center. Am Heart J. 1997;134:901–909
  21. Philbin EF. Factors determining angiotensin-converting enzyme inhibitor underutilization in heart failure in a community setting. Clin Cardiol. 1998;21:103–108
  22. Rich MW, Brooks K, Luther P. Temporal trends in pharmacotherapy for congestive heart failure at an academic medical center: 1990-1995. Am Heart J. 1998;135:367–372
  23. Spencer F, Scleparis G, Goldberg RJ, Yarzebski J, Lessard D, Gore JM. Decade long trends (1986 to 1997) in the medical management of patients with acute myocardial infarction: a community-wide perspective. Am Heart J. 2001;142:594–603
  24. Chandra H, Yarzebski J, Goldberg RJ, et al. Age-related trends (1986-1993) in the use of thrombolytic agents in patients with acute myocardial infarction: The Worcester Heart Attack Study. Arch Intern Med. 1997;157:741–746
  25. Rich MW, Beckham V, Wittenberg C, Leven CL, Freedland KE, Carney RM. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med. 1995;333:1190–1195
  26. Fonarow GC, Stevenson LW, Walden JA, et al. Impact of a comprehensive heart failure management program on hospital readmission and functional status of patients with advanced heart failure. J Am Coll Cardiol. 1997;30:725–732
  27. Pezzella SM, O’Mara P, Donahue JN. An ambulatory care program for managing high-risk congestive heart failure patients. J Clin Outcomes Manag. 1997;4:27–31

 Grant support for this project was provided by the National Heart, Lung, and Blood Institute (R01 HL69874).

PII: S0002-9343(06)00679-6

doi: 10.1016/j.amjmed.2006.05.051

The American Journal of Medicine
Volume 120, Issue 1 , Pages 98.e1-98.e8 , January 2007

Article Tools

* Image Usage & Resolution